Can-Fite BioPharma Ltd. (CANF) Shareholders’ equity 2017–2025
Can-Fite BioPharma Ltd. (CANF) shareholders’ equity at each fiscal year-end, per SEC filings.
$5.6MFY2025 · since FY2017: $3.0M → $5.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $5.6M | +2.9% |
| FY2024 | $5.4M | -12.9% |
| FY2023 | $6.2M | +39.6% |
| FY2022 | $4.5M | -68.9% |
| FY2021 | $14.4M | +136.8% |
| FY2020 | $6.1M | +148.7% |
| FY2019 | $2.4M | -19.0% |
| FY2018 | $3.0M | +1.0% |
| FY2017 | $3.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice